WOCKHARDT LTD. - 532300 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for transfer of equity shares to IEPF in the following newspapers: 1. Business Standard - all editions 2. Navshakti - Mumbai edition WOCKHARDT LTD. - 532300 - Closure of Trading Window
This is to inform you that pursuant to the Company''s Code of Conduct for regulating, monitoring and reporting trading by Designated persons'' (''the Code''), the Trading window for dealing in the equity shares of the Company will be closed from 1st January, 2024 until 48 (Forty-eight) hours after the declaration of unaudited financial results of the Company for the quarter and nine months ended 31st December, 2023. An antibiotics pipeline holds out promise for Wockhardt
Nafithromycin poised for domestic launch next year; company scouts for licensing partners
Wockhardt shares hit 52-week high, rally over 18%; here's why
Wockhardt share price surged to a 52-week peak of 398.95 per share on the BSE on Monday. WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Wockhardt announces successful completion of pivotal Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873. WOCKHARDT LTD. - 532300 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the requirement of Regulation 39(3) of SEBI Listing Regulations, we wish to inform that our RTA has intimated about receipt of request for issuance of Duplicate Share Certificate in lieu of original share certificate reported lost/misplaced. WOCKHARDT LTD. - 532300 - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September, 2023
Pursuant to Regulation 30 and 33 of the Listing Regulations read with Schedule III of the Listing Regulations, we enclose herewith Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023 along with the Limited Review Report thereon issued by B S R & Co. LLP Statutory Auditors of the Company as approved in the Board Meeting held on 14.11.2023. WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of SEBI Listing Regulations, please find enclosed Press Release on the Unaudited Financial Results(Standalone and Consolidated) for the quarter and half year ended 30th September, 2023. WOCKHARDT LTD. - 532300 - Board Meeting Outcome for Outcome Of The Board Meeting
Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2023-24/054 dated 6th November, 2023, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 14th November, 2023, inter-alia, have approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2023.